The New York Times reports:
The Food and Drug Administration is pushing to approve Pfizer-BioNTech’s two-dose Covid-19 vaccine on Monday, further expediting an earlier timeline for licensing the shot, according to people familiar with the agency’s planning.
Regulators were working to finish the process by Friday but were still working through a substantial amount of paperwork and negotiation with the company.
The people familiar with the planning, who were not authorized to speak publicly about it, cautioned that the approval might slide beyond Monday if some components of the review need more time.
Read the full article.
FDA reportedly could fully approve the Pfizer COVID-19 vaccine next week.https://t.co/XhBFRWWf4L
— Ken Yeung (@thekenyeung) August 20, 2021